| First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open … P Joly, M Maho-Vaillant, C Prost-Squarcioni, V Hebert, E Houivet, S Calbo, ... The Lancet 389 (10083), 2031-2040, 2017 | 506 | 2017 |
| Higher frequency of dipeptidyl peptidase-4 inhibitor intake in bullous pemphigoid patients than in the French general population M Plaquevent, F Tétart, L Fardet, S Ingen-Housz-Oro, L Valeyrie-Allanore, ... Journal of Investigative Dermatology 139 (4), 835-841, 2019 | 82 | 2019 |
| Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect DM Chen, A Odueyungbo, E Csinady, L Gearhart, P Lehane, M Cheu, ... British Journal of Dermatology 182 (5), 1111-1119, 2020 | 67 | 2020 |
| Risk factors for treatment failure in scabies: a cohort study A Aussy, E Houivet, V Hébert, H Colas‐Cailleux, N Laaengh, C Richard, ... British journal of dermatology 180 (4), 888-893, 2019 | 67 | 2019 |
| Large international validation of ABSIS and PDAI pemphigus severity scores V Hebert, C Boulard, E Houivet, SD Lehembre, L Borradori, R Della Torre, ... Journal of investigative dermatology 139 (1), 31-37, 2019 | 62 | 2019 |
| French study group on autoimmune bullous skin diseases. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3 … P Joly, M Maho-Vaillant, C Prost-Squarcioni, V Hebert, E Houivet, S Calbo, ... Lancet 389 (10083), 2031-2040, 2017 | 61 | 2017 |
| Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy: a post hoc analysis of a randomized clinical trial C Mignard, M Maho-Vaillant, ML Golinski, P Balayé, C Prost-Squarcioni, ... JAMA dermatology 156 (5), 545-552, 2020 | 51 | 2020 |
| A single typical trichoscopic feature is predictive of tinea capitis: a prospective multicentre study F Dhaille, AS Dillies, F Dessirier, P Reygagne, M Diouf, T Baltazard, ... British Journal of Dermatology 181 (5), 1046-1051, 2019 | 46 | 2019 |
| International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut‐off values for defining mild, moderate and severe types of bullous … W Masmoudi, M Vaillant, S Vassileva, A Patsatsi, G Quereux, C Moltrasio, ... British Journal of Dermatology 184 (6), 1106-1112, 2021 | 41 | 2021 |
| Rituximab in pemphigus V Hebert, P Joly Immunotherapy 10 (1), 27-37, 2018 | 38 | 2018 |
| Sensitivity and specificity of BP180 NC16A enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis F Al Saif, F Jouen, V Hebert, H Chiavelli, B Darwish, S Duvert-Lehembre, ... Journal of the American Academy of Dermatology 76 (3), 560-562, 2017 | 27 | 2017 |
| Modifications of the transcriptomic profile of autoreactive B cells from pemphigus patients after treatment with rituximab or a standard corticosteroid regimen V Hébert, M Petit, M Maho-Vaillant, ML Golinski, G Riou, C Derambure, ... Frontiers in Immunology 10, 458420, 2019 | 22 | 2019 |
| Linear IgA bullous dermatosis treated with rituximab C Pinard, V Hebert, M Lecuyer, L Sacre, P Joly JAAD case reports 5 (2), 124-126, 2019 | 22 | 2019 |
| Mixed individual-aggregate data on all-cause mortality in bullous pemphigoid: a meta-analysis B Tedbirt, A Gillibert, E Andrieu, V Hébert, S Bastos, NJ Korman, ... JAMA dermatology 157 (4), 421-430, 2021 | 21 | 2021 |
| Rituximab and corticosteroid effect on desmoglein-specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus M Maho-Vaillant, C Perals, ML Golinski, V Hébert, F Caillot, C Mignard, ... Journal of Investigative Dermatology 141 (9), 2132-2140. e1, 2021 | 18 | 2021 |
| Incidence and severity of COVID-19 in patients with autoimmune blistering skin diseases: A nationwide study P Joly, A Gillibert, G Bohelay, K Aouar, S Ingen-Housz-Oro, C Bedane, ... Journal of the American Academy of Dermatology 86 (2), 494-497, 2022 | 17 | 2022 |
| Lack of association between chilblains outbreak and severe acute respiratory syndrome coronavirus 2: histologic and serologic findings from a new immunoassay V Hébert, AB Duval-Modeste, P Joly, V Lemée, L Cellier, F Jouen, ... Journal of the American Academy of Dermatology 83 (5), 1434-1436, 2020 | 17 | 2020 |
| Ipilimumab-induced renal granulomatous arteritis: a case report M Lemoine, B Dilly, A Curie, V Hébert, C Laurent, M Hanoy, S Grangé, ... BMC nephrology 20, 1-5, 2019 | 15 | 2019 |
| A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices E Kechichian, S Ingen‐Housz‐Oro, E Sbidian, F Hemery, C Bernier, ... British Journal of Dermatology 179 (4), 1009-1011, 2018 | 14 | 2018 |
| Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first‐line treatment with rituximab vs. standard corticosteroid regimen … V Hébert, T Vermeulin, L Tanguy, B Tedbirt, C Mignard, J Bénichou, ... British Journal of Dermatology 183 (1), 121-127, 2020 | 12 | 2020 |
